Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rhys G. Morgan"'
Autor:
Megan Wagstaff, Olga Tsaponina, Gilian Caalim, Hayley Greenfield, Leanne Milton-Harris, Erika J. Mancini, Allison Blair, Kate J. Heesom, Alex Tonks, Richard L. Darley, Stefan G. Roberts, Rhys G. Morgan
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/a6ff5983437d400480a77a8722f391de
Publikováno v:
MethodsX, Vol 5, Iss , Pp 1473-1483 (2018)
Flow cytometric methods for detecting and quantifying reduced intracellular thiol content using fluorescein-5-maleimide (F5M) in viable eukaryotic cells date back to 1983 (Durand and Olive [1]). There has been little development in these methodologie
Externí odkaz:
https://doaj.org/article/705c6ca9808142cca36f0c7c6650d22f
Autor:
Rhys G. Morgan, Jenna Ridsdale, Megan Payne, Kate J. Heesom, Marieangela C. Wilson, Andrew Davidson, Alexander Greenhough, Sara Davies, Ann C. Williams, Allison Blair, Marian L. Waterman, Alex Tonks, Richard L. Darley
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Canonical Wnt/β-catenin signaling is frequently dysregulated in myeloid leukemias and is implicated in leukemogenesis. Nuclear-localized β-catenin is indicative of active Wnt signaling and is frequently observed in acute myeloid leukemia (AML) pati
Externí odkaz:
https://doaj.org/article/67f282a8773c4e4da92b6fe97861268a
Autor:
Joanna Zabkiewicz, Lorna Pearn, Robert K. Hills, Rhys G. Morgan, Alex Tonks, Alan K. Burnett, Richard L. Darley
Publikováno v:
Haematologica, Vol 99, Iss 5 (2014)
PDK1 is a master kinase that activates at least six protein kinase groups including AKT, PKC and S6K and is a potential target in the treatment of a range of malignancies. Here we show overexpression of PDK1 in over 40% of myelomonocytic acute leukem
Externí odkaz:
https://doaj.org/article/4918f0a34d444548abd0899cbb4f7bb5
Autor:
Christopher Parker, Adam C. Chambers, Dustin J. Flanagan, Jasmine Wing Yu Ho, Tracey J. Collard, Greg Ngo, Duncan M. Baird, Penny Timms, Rhys G. Morgan, Owen J. Sansom, Ann C. Williams
Publikováno v:
Parker, C, Chambers, A C, Flanagan, D J, Ho, J W Y, Collard, T J, Ngo, G, Baird, D M, Timms, P, Morgan, R G, Sansom, O J & Williams, A C 2022, ' BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination ', DNA repair, vol. 115, 103331 . https://doi.org/10.1016/j.dnarep.2022.103331
The proto-oncogene BCL-3 is upregulated in a subset of colorectal cancers (CRC), where it has been shown to enhance tumour cell survival. However, although increased expression correlates with poor patient prognosis, the role of BCL-3 in determining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b79364554502afec628f6dd8f54280
Acute myeloid leukaemia (AML) is an aggressive disease of the bone marrow with a poor prognosis. Evidence suggests long established chemotherapeutic regimens used to treat AML are reaching the limits of their efficacy, necessitating the urgent develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57e4404ecc9444219e65e71c060195b
http://sro.sussex.ac.uk/id/eprint/105241/1/BSR-2021-1841CR1_Merged_PDF.pdf
http://sro.sussex.ac.uk/id/eprint/105241/1/BSR-2021-1841CR1_Merged_PDF.pdf
Autor:
Samuel Olaitan, Megan Wagstaff, Okan Sevim, Raquel Akieme, Valentina Toska, Caroline Humphreys, Lorraine Shah‐Goodwin, John Bell, Timothy Chevassut, Rhys G. Morgan
Publikováno v:
European Journal of Haematology. 109:787-788
Autor:
Allison Blair, Erika J. Mancini, O Tsaponina, Stefan G. E. Roberts, L Milton-Harris, Amanda Jayne Tonks, G Caalim, M Payne, Richard Lawrence Darley, Kate J. Heesom, H Greenfield, Rhys G. Morgan
Publikováno v:
Haematologica. 108(1)
Wnt signalling is an evolutionary conserved signal transduction pathway heavily implicated in normal development and disease. The central mediator of this pathway, β-catenin, is frequently overexpressed, mislocalised and overactive in acute myeloid
Autor:
Christopher Parker, Greg H.P. Ngo, Duncan M. Baird, Owen J. Sansom, Dustin J. Flanagan, Ann C. Williams, Adam C. Chambers, Rhys G. Morgan, Tracey J Collard, Penny Timms
ObjectiveThe proto-oncogene BCL-3 is upregulated in a subset of colorectal cancers (CRC) and increased expression of the gene correlates with poor patient prognosis. The aim is to investigate whether inhibiting BCL-3 can increase the response to DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743f9ae6fd320dab2383458578eecc39
https://doi.org/10.1101/2021.08.03.454995
https://doi.org/10.1101/2021.08.03.454995
Autor:
Alex Gibbs, Samantha Sinnadurai, Leigh-anne Thomas, Zhengke Wang, Alfonso Garcia-Valverde, Neil P. Rodrigues, Rhys G. Morgan, Allison Blair, Maria Konstantinou, Ashleigh S. Boyd, Magali Boyer, Juan Bautista Menendez-Gonzalez
Publikováno v:
Menendez-Gonzalez, J B, Sinnadurai, S, Gibbs, A, Thomas, L, Konstantinou, M, Garcia-Valverde, A, Boyer, M, Wang, Z, Boyd, A S, Blair, A, Morgan, R G & Rodrigues, N P 2019, ' Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells ', Scientific Reports, vol. 9, 12212 (2019) . https://doi.org/10.1038/s41598-019-48589-0
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
GATA2, a zinc finger transcription factor predominantly expressed in hematopoietic cells, acts as an essential regulator of hematopoietic stem cell generation, survival and functionality. Loss and gain of GATA2 expression has been implicated in myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed752adc01c3daba6e99fc29f36f8c76
https://hdl.handle.net/1983/0fc9de71-230b-42b8-abd9-5194ca97349c
https://hdl.handle.net/1983/0fc9de71-230b-42b8-abd9-5194ca97349c